{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:35Z","timestamp":1786982195211,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100015613","name":"Centre Hospitalier Universitaire de Lille","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100015613","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Epstein-Barr virus (EBV) is suspected of being involved in the pathogenesis of several autoimmune diseases. However, its role in pancreatic islet autoimmunity remains to be determined. In the present study, the relationship between EBV serostatus and serum level of glutamic acid decarboxylase autoantibodies (GADA), a common marker of pancreatic islet autoimmunity, was investigated. Serum samples were collected from 158 individuals (aged 2\u201325 years) with GADA levels\u2009\u2265\u20090.7 U\/mL and the EBV serostatus of each individual was determined. EBV seropositive (EBV+) individuals were defined as positive for both serum VCA IgG and EBNA IgG and EBV seronegative (EBV-) individuals were negative for these antibodies. Univariate and multivariate analyses were performed to investigate the association between EBV serostatus and GADA levels. EBV+ individuals tend to have lower GADA levels than EBV- individuals (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.053). After adjustment for gender and age, mean GADA levels were significantly lower in EBV+ individuals than in EBV- individuals (9.34 U\/mL versus 17.49 U\/mL, respectively,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.015). The lower GADA levels in EBV+ individuals suggest that there is an inverse relationship between pancreatic islet autoimmunity and EBV serostatus. Further studies are needed to investigate the role of EBV in pancreatic islet autoimmunity.\n                  <\/jats:p>","DOI":"10.1007\/s12026-026-09778-y","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T07:26:49Z","timestamp":1776497209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inverse relationship between Epstein-Barr virus serostatus and anti-glutamic acid decarboxylase autoantibody levels"],"prefix":"10.1007","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5522-4296","authenticated-orcid":false,"given":"Cyril","family":"Debuysschere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6544-9795","authenticated-orcid":false,"given":"Mahdi","family":"Ouafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2981-0803","authenticated-orcid":false,"given":"Magloire Pandoua","family":"Nekoua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Lobert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3926-4487","authenticated-orcid":false,"given":"Pascal","family":"Pigny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1106-9826","authenticated-orcid":false,"given":"Enagnon Kazali","family":"Alidjinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4301-2074","authenticated-orcid":false,"given":"Didier","family":"Hober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"9778_CR1","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.3390\/microorganisms11051262","volume":"11","author":"C Debuysschere","year":"2023","unstructured":"Debuysschere C, Nekoua MP, Hober D. Markers of Epstein-Barr Virus Infection in Patients with Multiple Sclerosis. Microorganisms. 2023;11:1262. https:\/\/doi.org\/10.3390\/microorganisms11051262.","journal-title":"Microorganisms"},{"key":"9778_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan SS, Lieberman PM. Epstein\u2013Barr virus and multiple sclerosis. Nat Rev Microbiol. 2023;21:51\u201364. https:\/\/doi.org\/10.1038\/s41579-022-00770-5.","journal-title":"Nat Rev Microbiol"},{"key":"9778_CR3","doi-asserted-by":"publisher","first-page":"587380","DOI":"10.3389\/fimmu.2020.587380","volume":"11","author":"G Houen","year":"2021","unstructured":"Houen G, Trier NH. Epstein-Barr virus and systemic autoimmune diseases. Front Immunol. 2021;11:587380.","journal-title":"Front Immunol"},{"key":"9778_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/j.1699-0463.1991.tb05162.x","volume":"99","author":"H Hy\u00f6ty","year":"1991","unstructured":"Hy\u00f6ty H, R\u00e4s\u00e4nen L, Hiltunen M, Lehtinen M, Huupponen T, Leinikki P. Decreased antibody reactivity to Epstein-Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus. APMIS Acta Pathol Microbiol Immunol Scand. 1991;99:359\u201363. https:\/\/doi.org\/10.1111\/j.1699-0463.1991.tb05162.x.","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand"},{"key":"9778_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2337\/db15-0179","volume":"65","author":"X Bian","year":"2015","unstructured":"Bian X, Wallstrom G, Davis A, Wang J, Park J, Throop A, Steel J, Yu X, Wasserfall C, Schatz D, Atkinson M, Qiu J, LaBaer J. Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays. Diabetes. 2015;65:285\u201396. https:\/\/doi.org\/10.2337\/db15-0179.","journal-title":"Diabetes"},{"key":"9778_CR6","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1159\/000543035","volume":"97","author":"MJ Haller","year":"2024","unstructured":"Haller MJ, Bell KJ, Besser REJ, Casteels K, Couper JJ, Craig ME, Elding Larsson H, Jacobsen L, Lange K, Oron T, Sims EK, Speake C, Tosur M, Ulivi F, Ziegler A-G, Wherrett DK, Marcovecchio ML. ISPAD Clinical Practice Consensus Guidelines 2024: Screening, Staging, and Strategies to Preserve Beta-Cell Function in Children and Adolescents with Type 1 Diabetes. Horm Res Paediatr. 2024;97:529\u201345. https:\/\/doi.org\/10.1159\/000543035.","journal-title":"Horm Res Paediatr"},{"key":"9778_CR7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00592-017-1091-x","volume":"55","author":"E Niechcia\u0142","year":"2018","unstructured":"Niechcia\u0142 E, Rogowicz-Frontczak A, Pi\u0142aci\u0144ski S, Fichna M, Skowro\u0144ska B, Fichna P, Zozuli\u0144ska-Zi\u00f3\u0142kiewicz D. Autoantibodies against zinc transporter 8 are related to age and metabolic state in patients with newly diagnosed autoimmune diabetes. Acta Diabetol. 2018;55:287\u201394. https:\/\/doi.org\/10.1007\/s00592-017-1091-x.","journal-title":"Acta Diabetol"},{"key":"9778_CR8","doi-asserted-by":"publisher","first-page":"e14712","DOI":"10.1111\/dme.14712","volume":"38","author":"AE Long","year":"2021","unstructured":"Long AE, George G, Williams CL. Persistence of islet autoantibodies after diagnosis in type 1 diabetes. Diabet Med. 2021;38:e14712. https:\/\/doi.org\/10.1111\/dme.14712.","journal-title":"Diabet Med"},{"key":"9778_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","volume":"20","author":"WH Robinson","year":"2024","unstructured":"Robinson WH, Younis S, Love ZZ, Steinman L, Lanz TV. Epstein\u2013Barr virus as a potentiator of autoimmune diseases. Nat Rev Rheumatol. 2024;20:729\u201340. https:\/\/doi.org\/10.1038\/s41584-024-01167-9.","journal-title":"Nat Rev Rheumatol"},{"key":"9778_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375:296\u2013301. https:\/\/doi.org\/10.1126\/science.abj8222.","journal-title":"Science"},{"key":"9778_CR11","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","volume":"391","author":"LA DiMeglio","year":"2018","unstructured":"DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(18)31320-5.","journal-title":"Lancet"},{"key":"9778_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/jmv.21373","volume":"81","author":"M De Paschale","year":"2009","unstructured":"De Paschale M, Agrappi C, Manco MT, Mirri P, Vigan\u00f2 EF, Clerici P. Seroepidemiology of EBV and interpretation of the isolated VCA IgG pattern. J Med Virol. 2009;81:325\u201331. https:\/\/doi.org\/10.1002\/jmv.21373.","journal-title":"J Med Virol"},{"key":"9778_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jinf.2008.07.017","volume":"57","author":"T Garc\u00eda","year":"2008","unstructured":"Garc\u00eda T, Tormo N, Gimeno C, Navarro D. Assessment of Epstein-Barr virus (EBV) serostatus by enzyme immunoassays: plausibility of the isolated EBNA-1 IgG positive serological profile. J Infect. 2008;57:351\u20133. https:\/\/doi.org\/10.1016\/j.jinf.2008.07.017.","journal-title":"J Infect"},{"key":"9778_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3390\/microorganisms13040733","volume":"13","author":"A Aubry","year":"2025","unstructured":"Aubry A, Francois C, Demey B, Louchet-Ducoroy M, Pannier C, Segard C, Brochot E, Castelain S. Evolution of Epstein\u2013Barr Virus Infection Seroprevalence in a French University Hospital over 11 Years, Including the COVID-19 Pandemic, 2013\u20132023. Microorganisms. 2025;13:733. https:\/\/doi.org\/10.3390\/microorganisms13040733.","journal-title":"Microorganisms"},{"key":"9778_CR15","doi-asserted-by":"publisher","first-page":"e13117","DOI":"10.1111\/ina.13117","volume":"32","author":"X Xu","year":"2022","unstructured":"Xu X, Du H, Lian Z. Discussion on regression analysis with small determination coefficient in human-environment researches. Indoor Air. 2022;32:e13117. https:\/\/doi.org\/10.1111\/ina.13117.","journal-title":"Indoor Air"},{"key":"9778_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/dmrr.420","volume":"20","author":"E Lindholm","year":"2004","unstructured":"Lindholm E, Hallengren B, Agardh C-D. Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. Diabetes Metab Res Rev. 2004;20:158\u201364. https:\/\/doi.org\/10.1002\/dmrr.420.","journal-title":"Diabetes Metab Res Rev"},{"key":"9778_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000053256","volume":"54","author":"JR Bilbao","year":"2000","unstructured":"Bilbao JR, Rica I, V\u00e1zquez JA, Busturia MA, Casta\u00f1o L. Influence of Sex and Age at Onset on Autoantibodies against Insulin, GAD65 and IA2 in Recent Onset Type 1 Diabetic Patients. Horm Res Paediatr. 2000;54:181\u20135. https:\/\/doi.org\/10.1159\/000053256.","journal-title":"Horm Res Paediatr"},{"key":"9778_CR18","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.2337\/dc23-0124","volume":"46","author":"J Tojjar","year":"2023","unstructured":"Tojjar J, Cervin M, Hedlund E, Brahimi Q, Forsander G, Elding Larsson H, Ludvigsson J, Samuelsson U, Marcus C, Persson M, Carlsson A. Sex Differences in Age of Diagnosis, HLA Genotype, and Autoantibody Profile in Children With Type 1 Diabetes. Diabetes Care. 2023;46:1993\u20136. https:\/\/doi.org\/10.2337\/dc23-0124.","journal-title":"Diabetes Care"},{"key":"9778_CR19","doi-asserted-by":"publisher","first-page":"12330","DOI":"10.1128\/jvi.01699-12","volume":"86","author":"SI Tracy","year":"2012","unstructured":"Tracy SI, Kakalacheva K, L\u00fcnemann JD, Luzuriaga K, Middeldorp J, Thorley-Lawson DA. Persistence of Epstein-Barr Virus in Self-Reactive Memory B Cells. J Virol. 2012;86:12330\u201340. https:\/\/doi.org\/10.1128\/jvi.01699-12.","journal-title":"J Virol"},{"key":"9778_CR20","doi-asserted-by":"publisher","unstructured":"Li J, Li B. EBNA-1 antibody and autoimmune rheumatic diseases: a Mendelian randomization study. Heliyon. 2024;10. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e37045.","DOI":"10.1016\/j.heliyon.2024.e37045"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09778-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09778-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09778-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:21:08Z","timestamp":1781648468000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09778-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9778"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09778-y","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research project complies with the MR004 reference methodology of the French National Commission on Informatics and Liberty (CNIL) and has been registered in the institution's data processing registry under the number DEC24-265.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical considerations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}